IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myelomaEileen M. Boyle, Xavier Leleu, Hélène Demarquette et al.|Cancer|2014Cited by 36
Safety Profile of Bortezomib Impacts Survival in Light Chain AmyloidosisZoé Van de Wyngaert, Xavier Leleu, Greg Vanoutryve et al.|Blood|2014Cited by 0